TABLE 5.

Unadjusted and Adjusted ORs for Major Adverse Outcomes at 18 to 22 Months of Age Corrected for Prematurity in Epoch 2 Compared With Epoch 1

Model	Epoch 2 vs 1, OR (95% CI)	P
Neurodevelopmental Impairment
Unadjusted	1.41 (1.06–1.88)	.019
Model 1	1.30 (0.96–1.77)	.096
Model 2	1.22 (0.87–1.72)	.246
Model 2 plus PNS	1.41 (0.98–2.04)	.066
MDI < 70
Unadjusted	1.28 (0.96–1.70)	.092
Model 1	1.21 (0.89–1.65)	.220
Model 2	1.12 (0.80–1.56)	.513
Model 2 plus PNS	1.30 (0.91–1.87)	.154
Moderate-to-severe cerebral palsy
Unadjusted	1.41 (0.93–2.13)	.105
Model 1	1.23 (0.79–1.90)	.354
Model 2	1.22 (0.72–2.09)	.463
Model 2 plus PNS	1.52 (0.86–2.71)	.152

PNS indicates postnatal steroid use.